Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
WO2010144571A1
Histamine h3 inverse agonists and antagonists and methods of use thereof
WO2010114971A1
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
CN102340992A
Pyrrolidine triple reuptake inhibitors
US2010221338A1
Coated Tablets Of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine And Methods For Measuring Effectiveness Of Coating
US2010120740A1
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US2010029737A1
Inhibitors of D-amino acid oxidase
US2011009416A1
PH INDEPENDENT FORMULATIONS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE
US2011053945A1
Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihy-dro-5h-pyrrolo[3,4-b]pyrazine
TW200913984A
Acetamide stereoisomer
US2009060917A1
Carbamate Stereoisomer
NZ580429A
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
TW200906833A
Fused heterocyclic inhibitors of D-amino acid oxidase
CN101686955A
Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders
US2008234247A1
Heterocyclic analgesic compounds and methods of use thereof
AU2008200875A1
Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
CN101663263A
Solid forms comprising (-) o-desmethylvenlafaxine and uses thereof
